While the role of such combined approaches in thyroid cancer remains unexplored, atezolizumab (an anti-PD-L1 agent) increased the expressions of claudin-1 and occludin in murine ileum during sepsis [49]. This evidence concerns the gene OCLN and thyroid cancer.